• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,165
2,283
1,853
1,828
1,712

COUNTRY

871
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,126
    • 99
  • 385
  • 270
  • 252
  • 65
  • 379
  • 673
  • 1,276
  • 1,621
  • 625
  • 883
  • 1,674
  • 2,641
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 726
  • 0
  • 97

PRICE

6,961
11,316
17,030
24,701

PUBLISHED

262
2,358
6,795
24,701

PRODUCT TYPE

20,325
3,174
857
164
74
44
21
21
14
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Atherosclerosis - Pipeline Review, H1 2014

Atherosclerosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H1 2014’, provides an overview of the Atherosclerosis’s therapeutic pipeline. This...

February 2014
FROM

Peanut Allergy - Pipeline Review, H1 2014

Peanut Allergy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H1 2014’, provides an overview of the Peanut Allergy’s therapeutic pipeline. This report...

February 2014
FROM

Pentasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Pentasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson &...

February 2014
FROM

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson &...

February 2014
FROM

Remicade (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Remicade (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson &...

February 2014
FROM

Saphris (Schizophrenia) - Forecast and Market Analysis to 2022

Saphris (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms,...

February 2014
FROM

Indolent Lymphoma Global Clinical Trials Review, H1, 2014

Indolent Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Indolent Lymphoma clinical...

February 2014
FROM

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Brain Tumor - Pipeline Review, H1 2014

Brain Tumor - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Tumor - Pipeline Review, H1 2014’, provides an overview of the Brain Tumor’s therapeutic pipeline. This report provides...

February 2014
FROM

Neuropathic Pain - Pipeline Review, H1 2014

Neuropathic Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This...

February 2014
FROM

Brain Metastasis - Pipeline Review, H1 2014

Brain Metastasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Metastasis - Pipeline Review, H1 2014’, provides an overview of the Brain Metastasis’s therapeutic pipeline. This...

February 2014
FROM

Kidney Fibrosis - Pipeline Review, H1 2014

Kidney Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H1 2014’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline. This...

February 2014
FROM

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Liver Failure - Pipeline Review, H1 2014

Liver Failure - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liver Failure - Pipeline Review, H1 2014’, provides an overview of the Liver Failure’s therapeutic pipeline. This report...

February 2014
FROM

Cholera - Pipeline Review, H1 2014

Cholera - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2014’, provides an overview of the Cholera’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Epithelial Ovarian Cancer - Pipeline Review, H1 2014

Epithelial Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Epithelial Ovarian Cancer’s...

February 2014
FROM

Vulvovaginal Candidiasis - Pipeline Review, H1 2014

Vulvovaginal Candidiasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Vulvovaginal Candidiasis - Pipeline Review, H1 2014’, provides an overview of the Vulvovaginal Candidiasis’s therapeutic...

February 2014
FROM

Hemophilia A - Pipeline Review, H1 2014

Hemophilia A - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hemophilia A - Pipeline Review, H1 2014’, provides an overview of the Hemophilia A’s therapeutic pipeline. This report provides...

February 2014
FROM

Allergic Rhinitis - Pipeline Review, H1 2014

Allergic Rhinitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H1 2014’, provides an overview of the Allergic Rhinitis’s therapeutic pipeline. This...

February 2014
FROM
Loading Indicator

Our Clients

Our clients' logos